Brain Disorders and Therapeutics

Jan VERSIJPT is the Neurologist and Head of the Clinic for Head and Face Pain in the Brussels University Hospital.

Neurology, Dementia

Sam Vaknin is Visiting Professor of Psychology, Southern Federal University, Rostov-on-Don, Russia and Professor of Finance and Psychology in CIAPS (Centre for International Advanced and Professional Studies). Sam Vaknin is the author of Malignant Self-love: Narcissism Revisited and other books about personality disorders. His work is cited in hundreds of books and dozens of academic papers. He spent the past 6 years developing Cold Therapy: a treatment modality for Narcissistic Personality Disorder (NPD). Over the years, with dozens of volunteers, he found that it was effective with clients suffering from a major depressive episode as well.

Personality disorders

Chris Gamblin completed his PhD with Dr. Robley Williams, Jr. at Vanderbilt University and postdoctoral studies with Dr. Skip Binder at Northwestern University Feinberg School of Medicine. He is currently an Associate Professor in the Department of Molecular Biosciences at the University of Kansas and continues to investigate the biochemical mechanisms of tau aggregation.

Biochemical mechanisms

Hernández, Ph.D. has been studying traumatic brain injury (TBI) using basic and clinical neuroscience models since 1985. Her ongoing, extramurally funded research program assesses the degree to which recovery and functional outcome after TBI can be optimized in a variety of populations (Veterans, civilians, athletes). This includes conducting randomized, placebo-controlled, blinded trials of novel interventions, such as acupressure. This work is accomplished through her appointment as Professor and Chair of the Department of Psychology & Neuroscience at CU Boulder, her appointment as a Senior Investigator and Research Psychologist in the Eastern Colorado Healthcare System, Rocky Mountain MIRECC (Mental Illness, Research, Education & Clinical Center) and through her role as one of the co-Directors of the PAPRR (Promoting Athlete Performance, Recovery and Resilience) Board at CU Boulder. She is also the Director of the CAIRR (Clinical Assessment of Injury, Recovery and Resilience) Neuroscience Laboratory.

clinically-based program of research is aimed at providing an experimental basis for improving clinical treatment following brain insult so that neurobehavioral function is optimized. We are currently accomplishing this via two tracks: one aimed at the initial post-injury period and a second focusing on the stable post-insult period.

Wayne Grant Carter received his Honours degree and PhD in Biochemistry from the University of Southampton, studying protein post-translational modification and molecular signalling cascades. He is currently a Group Leader in the School of Medicine, University of Nottingham, with research focused upon protein post-translational modification and molecular mechanisms of hepato- and neuro-toxicity.

Molecular mechanisms of hepato- and Neuro-toxicity

Toborek has completed his MD and PhD from the Silesian Medical University, Poland, and completed his postdoctoral training at the University of Kentucky. He is the Vice-Chair for Research in the Department of Biochemistry and Molecular Biology. Research in Dr. Toborek’s laboratory has been focused on several aspects of vascular biology. Specific interest involves studies on the integrity of the blood-brain barrier (BBB) and how different pathological conditions can lead to the disruption and/or dysfunction of the BBB. He has published numerous manuscripts related to this field and has been serving as an editorial board member of many journals.

Toborek’s laboratory involve studies on the integrity of the blood-brain barrier (BBB) and how different pathological conditions can lead to the disruption and/or dysfunction of the BBB.

Lynne Hughes has worked in clinical research for more than 33 years and has lived and worked during this time period in both the US and in Europe. She has been with IQVIA for 21 years and is currently Vice President and Global Head, Medical Strategy, Neurology. She has provided consultancy advice in Alzheimer’s disease, multiple sclerosis, acute care including TBI and stroke, migraine, epilepsy and pain, and has been involved in a number of investment opportunities within IQVIA. She sits on a number of advisory boards, with particular interest in neurocognitive assessment and design of appropriate studies to assess AD & neurocognitive dysfunction. She is a member of a number of steering and / or executive committees for clients and has responsibility for several consultancy programs for investment opportunities within all areas of neurology. Her current role is in developing evidence-based strategies for the most efficient conduct of clinical trials / programs for our clients and leads the Medical Strategy team which provides therapeutic input and expertise for conducting trials in subjects across all neurological and pain indications. She has been involved, to varying extents, in the development of every neurology product on the market today. She has been involved in all of IQVIAs AD trials – and this is more than 82 trials, many of which were global, over the past 10 years. She is PMP certified and has been since 2000 and this certification is up to date.

Alzheimer’s disease, Parkinson’s disease, Neurocognitive dysfunction.

Hans von Holst received his Medical Doctor´s degree in 1976 and specialist in Neurosurgery 1982 at Karolinska University Hospital. In 1985 he earned his PhD and Associate Professorship in Neurosurgery, Clinical Neuroscience at Karolinska Institutet. During 1991-1996 he was appointed as Chairman of the Dept of Neurosurgery and Division Manager of the Neuroclinics at Karolinska University Hospital, respectively. In 1995 he became Professor in Neuroengineering at the Royal Institute of Technology. He has published around 140 original papers in reputed journals, reviews and books and has been serving as an editorial board member in several journals.

traumatic brain injury and stroke

John L Merritt graduated from the Medical University of South Carolina (MD) and did residencies at Huntington Hospital (University of Southern California) and The Mayo Clinic, Rochester Minnesota. He is an Emeritus Professor, University of South Florida, Medicine & Neurology, and has served as Professor at the Mayo Clinic, University of Southern California, Irvine, Medical College of Wisconsin and University of South Florida, Tampa. He is board certifi ed in Brain Injury Medicine, Spinal Cord Medicine, Physical Medicine & Rehabilitation and Internal Medicine. He is Medical Advisor to Stay in Step SCI Recovery Center and President of RehabMed South

Neuro-regeneration, Olfactory Mucosal Autografts, Stem Cell Therapies Spinal Cord Injury Acute and Chronic, Outcomes; Prevention of Urinary Tract Infections Prevention of Urinary Tract Infection in Spinal Cord Injury Pressure Ulcer Prevention and Management; Respiratory Intervention in Quadriplegia Energy Expenditure in Paraplegia; Metabolic Changes in Chronic SCI Ethics, Beginning and End of Life Issues, Palliative Care Amyotrophic Lateral Sclerosis, Outcome Prediction and Management Life Expectancy and Outcomes in Spinal Cord Injury

Ramesh Gupta is Vice Chancellor of Radha Govind University Ramghar, Jharkhand India. Before joining this place for 40 years, Prof Gupta was professor & Pro Vice chancellor at Nagaland central University India He received at the age of 23, his Doctorate in Chemistry at Lucknow University, on Drug Development. Dr. Ramesh Gupta is a Medicinal & Bioorganic Chemist and has worked for several years as visiting professor/Scientist in various Medical schools; Louis pasture University France, University of Arizona USA, Osaka University & Nagoya University Japan, Kyung Hee University, Korea advance institute of science and technology (KAIST) Korea, Ben-Gurion University Israel, Linkoping University Sweden, University of Mons Belgium, University of Western Australia, Sydney ,University of Bergen ,Norway and some others.

Natural & Synthetic Drug Development, role of sulfur amino acids in health care, functional food, nutraceuticals and environmental Biotechnology & gender issues.